Evidence map›Paper›PMID 35545681›Full record

ArticleBritish journal of cancer2022

Intensity of care in cancer patients in the last year of life: a retrospective data linkage study.

Xhyljeta Luta, Katharina Diernberger, Joanna Bowden, Joanne Droney, Peter Hall, Joachim Marti

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Dyadic-concordance death-preparedness states and end-of-life care received by cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Predicting 1-year mortality in older cancer patients: performance of G8, SPPB, and IF-VIG in the PROFIT Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Xhyljeta LutaCentre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland. xhyljeta.luta@chuv.ch.ORCID http://orcid.org/0000-0002-5716-4693
Katharina DiernbergerUniversity of Edinburgh, Edinburgh Clinical Trials Unit, Usher Institute, Edinburgh, UK.
Joanna BowdenEdinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.
Joanne DroneyInstitute of Global Health Innovation, Department of Surgery and Cancer, Imperial College London, London, UK.
Peter HallUniversity of Edinburgh, Edinburgh Clinical Trials Unit, Usher Institute, Edinburgh, UK.ORCID http://orcid.org/0000-0001-6015-7841
Joachim MartiCentre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Edinburgh Cancer Research · GBCentre universitaire de médecine générale et santé publique, Lausanne · CHRoyal Marsden NHS Foundation Trust · GBUniversity Hospital of Lausanne · CHUniversity of St Andrews · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelivering high-quality palliative and end-of-life care for cancer patients poses major challenges for health services. We examine the intensity of cancer care in England in the last year of life.

methodsWe included cancer decedents aged 65+ who died between January 1, 2010 and December 31, 2017. We analysed healthcare utilisation and costs in the last 12 months of life including hospital-based activities and primary care.

resultsHealthcare utilisation and costs increased sharply in the last month of life. Hospital costs were the largest cost elements and decreased with age (0.78, 95% CI: 0.73-0.72, p < 0.005 for age group 90+ compared to age 65-69 and increased substantially with comorbidity burden (2.2, 95% CI: 2.09-2.26, p < 0.005 for those with 7+ comorbidities compared to those with 1-3 comorbidities). The costs were highest for haematological cancers (1.45, 95% CI: 1.38-1.52, p < 0.005) and those living in the London region (1.10, 95% CI: 1.02-1.19, p < 0.005).

conclusionsHealthcare in the last year of life for advanced cancer patients is costly and offers unclear value to patients and the healthcare system. Further research is needed to understand distinct cancer populations' pathways and experiences before recommendations can be made about the most appropriate models of care.

Indexed as

NeoplasmsTerminal CareHumansInfant, NewbornInformation Storage and RetrievalPalliative CareRetrospective Studies

Identifiers

PMID35545681
PMCPMC9092325
OpenAlexW4280545069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.